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Abstract: Human milk composition is dynamic, and substitute formulae are intended to mimic its
protein content. The purpose of this study was to investigate the potentiality of matrix-assisted laser
desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS), followed by multivariate
data analyses as a tool to analyze the peptide profiles of mammalian, human, and formula milks.
Breast milk samples from women at different lactation stages (2 (n = 5), 30 (n = 6), 60 (n = 5),
and 90 (n = 4) days postpartum), and milk from donkeys (n = 4), cows (n = 4), buffaloes (n = 7),
goats (n = 4), ewes (n = 5), and camels (n = 2) were collected. Different brands (n = 4) of infant
formulae were also analyzed. Protein content (<30 kDa) was analyzed by MS, and data were exported
for statistical elaborations. The mass spectra for each milk closely clustered together, whereas different
milk samples resulted in well-separated mass spectra. Human samples formed a cluster in which
colostrum constituted a well-defined subcluster. None of the milk formulae correlated with animal
or human milk, although they were specifically characterized and correlated well with each other.
These findings propose MALDI-TOF MS milk profiling as an analytical tool to discriminate, in a
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Nutrients 2018, 10, 1238 2 of 13
blinded way, different milk types. As each formula has a distinct specificity, shifting a baby from one
to another formula implies a specific proteomic exposure. These profiles may assist in milk proteomics
for easiness of use and minimization of costs, suggesting that the MALDI-TOF MS pipelines may be
useful for not only milk adulteration assessments but also for the characterization of banked milk
specimens in pediatric clinical settings.
Keywords: infant nutrition; breast milk; mammalian milk; formula milk; protein similarity profiling;
MALDI-TOF mass spectrometry
1. Introduction
Breast milk is the primary food source for newborn mammals, and the World Health Organization
recommends that infants should be exclusively breastfed for the first six months of life [1,2].
BM synthesis is subtly regulated at a local level [3], and its composition is influenced by several
factors such as animal species and genetics, environmental conditions, and animal nutritional status [4].
Human milk (HM) composition varies with gestational age, lactation stage (transition from colostrum
to late lactation), within feeds, diurnally, and amongst mothers [5,6]. HM provides proteins, tricalcium
phosphate, lipids, vitamins, salt, and lactose; it also contains many hundreds to thousands of distinct
bioactive molecules which protect against infection and inflammation and contribute to immune
maturation, organ development, and healthy microbial colonization [7].
Despite many campaigns for the promotion of breastfeeding, only 38% of infants in the world are
exclusively breastfed [8,9]. When HM becomes unsuitable or inadequate, its ideal substitutions are the
infant formulae, defined as “a breast milk substitute specially manufactured to satisfy, by itself,
the nutritional requirements of infants during the first months of life up to the introduction of
appropriate complementary feeding” [10]. Unlike the dynamic composition of HM, infant formulae
are standard products with a composition that is highly regulated by the authorities. To date,
the most commonly recommended infant formulae are based on cow milk [11]. The Food and Drugs
Administration (FDA) in the US and the European Society for Pediatric Gastroenterology Hepatology
and Nutrition (ESPGHAN) in Europe recommended that the formulae should be enriched in whey
protein fractions and lowered in caseins [9,12]. The worldwide recommendations are primarily based
on the chemical analysis of human milk, and manufacturers are continually modifying their products to
make them more similar to human breast milk, the gold standard to estimate the needs of an infant [13],
and to increase their health benefits, including iron, nucleotides, prebiotics, and compositions of fat
blends [14]. In this context, the number of studies on HM and its protein composition has dramatically
increased during the last half century [15–19]. For children with a cow’s milk allergy (CMA) whose
mother cannot breastfeed, milk from different mammals has been evaluated, but no milk formulae from
animals other than cows has been formulated, and cross-reactivity is possible between the proteins
of cows and other mammalian milk [20]. Thus, other animal-milk-based formulae are currently not
recommended [21].
The recommendations on substitute formulae in cases of lactation failure are based on many
factors, but nutritional considerations are one of the prominent factors. Among the nutritional factors,
proteins are the most important. This study aims to investigate the potentiality of linear matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as a tool to assess
the diversity and oddness of different artificial and mammalian kinds of milk compared to the
reference human milk. MALDI-TOF MS is a platform adopted by many healthcare clinical laboratories
worldwide owing to its simplicity of use, high reproducibility of the mass spectra, and low cost of
the analysis [22]. Recently, this technique has been proposed as a powerful tool to obtain informative
fingerprints of milk proteins [23]. The identification of differences and similarities among several types
of artificial and animal milk compared to the reference human milk at different stages of lactation
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could assist the design of infant formulae. Furthermore, a MALDI-TOF MS-based approach coupled
with a multivariate statistical assessment of MS data could represent a versatile workflow to evaluate
the quality and safety of sample milk in blind for nonspecialized, mass-spectrometric laboratories.
2. Materials and Methods
2.1. Milk Sampling and Pre-Treatment
The human milk (HM) samples were collected from twenty healthy breastfeeding mothers at
the Department of Obstetrics and Gynecology, San Camillo Forlanini Hospital of Rome, Italy, at four
different periods of lactation: 2 days (colostrum, HC), 30 days (HM30), 60 days (HM60), and 90 days
(HM90). The study protocol was approved by the Ethics Committee of the San Camillo-Forlanini
Hospital (protocol 460/CE; 27/03/2012) and by the Institutional Review Board of the Bambino Gesù
Children’s Hospital (protocol 295 LB; 16/05/2012). Informed written consent was obtained from
all mothers. Raw donkey milk (DM) from four she-donkeys belonging to the Amiata, Viterbese,
and Martina Franca breeds, cow milk (CM) from four cows belonging to the Frisona breed, buffalo milk
(BM) from seven buffalos belonging to the Mediterranean Italian breed, goat milk (GM) from four goats
belonging to the Maltese breed, and ewe’s milk (EM) from five ewes belonging to the Tuscolania breed
were collected from Italian farms (Lazio and Puglia). Camel milk (CAM, from two Camelus dromedarius)
was collected from Libyan desert farms. Commercially available infant formula milk samples from
four different brands were also studied: Aptamil 1 (A) (Mellin SpA, Milan, Italy), Humana 1 (H)
(Humana Italia SpA, Milan, Italy), Formulat 1 (F) (Dicofarm, S.A., Rome, Italy), and Nidina 1 (N)
(Nestlé, S.A., Milan, Italy). For each brand, we obtained four samples from different batches that
were produced over a period of two years. All the animal milk samples were mechanically milked
during the middle lactation stage into sterile polystyrene containers, immediately frozen, and stored at
−80 ◦C until use to prevent undesired proteolysis. After thawing, raw milk samples were defatted by
a two-step centrifugation using the Eppendorf Centrifuge 5417 R (The LabWorld, Woburn, MA, USA).
The first centrifugation was performed at 3000× g for 10 min at 4 ◦C. The skimmed milk was then
centrifuged at 20,000× g for 20 min at 4 ◦C to remove bacteria and cell debris. The skimmed milk’s
fractions were subsequently diluted 1:100 with ultrapure water (Milli-Q Millipore) and subjected to
mass spectrometry analysis [23].
2.2. MALDI-TOF Spectra Acquisition
An aliquot (1 µL) of each skimmed milk’s fraction was directly spotted onto an MSP 96 polished
steel target (Bruker Daltonics, Bremen, Germany), overlaid with 1 L of matrix, represented by a
solution of 10 mg/mL of sinapinic acid (Sigma-Aldrich, St. Louis, MO, USA) in 50% acetonitrile
(Sigma-Aldrich, St. Louis, MO, USA), containing 0.1% trifluoroacetic acid (v/v) (Sigma-Aldrich,
St. Louis, MO, USA), and allowed to dry at room temperature. MALDI-TOF analysis was performed
with a Microflex LT linear mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with the
FlexControl software package, version 3.0 (Bruker Daltonics, Bremen, Germany), for spectra recording
in the positive linear mode (laser frequency 20 Hz; ion source 1 voltage, 20 kV; ion source 2 voltage,
18.4 kV; lens voltage, 9.1 kV; mass range, 2000 Da to 30,000 Da). Four independent spectra (500 shots
one step from different positions of the target spot, for spectrum) for each skimmed milk’s fraction
were manually collected, externally calibrated by using Bacterial Test Standard (Bruker Daltonics),
and subsequently analyzed.
2.3. Statistical Analysis
Before the statistical analysis was conducted, 200 mass spectra, as reported in Table 1,
were manually acquired and visually inspected. Subsequently, each spectra was loaded into
FlexAnalysis software, version 3.0 (Bruker Daltonics, Bremen, Germany), to perform mass adjustment
(spectra were compressed by a factor of 10 in the total mass range), smoothing (mass data were adjusted
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by the Savitsky–Golay algorithm with a frame size of 25 Da), baseline subtraction (was applied the
minimum value for finding the baseline), normalization (was applied the maximum norm to normalize
the baseline subtracted data), and peak picking (was applied spectra differentiation algorithm for
finding the peaks, maximum peaks 100, threshold 0.1, method Peak Fitting). The total preprocessed
raw datasets of the 200 milk spectra were imported into R Bioconductor (http://www.bioconductor.
org/) [24] for Pearson’s correlation analysis and hierarchical clustering. The package pvclust was
applied for bootstrapping. For each cluster generated by hierarchical computation, p-values (between
0 and 1) were calculated via multiscale bootstrap resampling. Two different p-values were provided
by the package pvclust: approximately unbiased (AU) and bootstrap probability (BP). AU was
computed by multiscale bootstrap resampling and represents a better approximation of an unbiased
p-value than a BP value computed by normal bootstrap resampling. The same preprocessed raw
datasets were imported into ClinProToolsTM bioinformatics software, version 2.2 (Bruker Daltonics,
Bremen, Germany) [25], and converted into a virtual gel-like format. The mass values (m/z) were
reported on the X axis, while the gray scale bar, reported on the Y axis, showed the relationship between
the color intensity and the peak intensity. Finally, principal component analysis (PCA) was performed
via ClinProToolsTM software, version 2.2 (Bruker Daltonics, Bremen, Germany), which employs only
the statistically significant peaks after group classification for the calculation. Based on a Welch’s
t-test, a p-value for each peak was calculated. This value indicates the probability that the observed
intensity differences among the various peaks are due to chance. These calculations have been done
independently for peak heights and peak areas.
Table 1. Milk samples analyzed and relative mass spectra acquired.
Milk Source Samples (n) Spectra Replicates (n) Total Spectra Analyzed (n)
Human milk
Breastfeeding women at 2 days 5 4 20
Breastfeeding women at 30 days 6 4 24
Breastfeeding women at 60 days 5 4 20
Breastfeeding women at 90 days 4 4 16
Commercial brands of infant formula 4 4 16
Animal milk 1
cows 4 4 16
buffaloes 7 4 28
goats 4 4 16
ewes 5 4 20
she-donkeys 4 4 16
camels 2 4 8
1 All animal milk samples were collected at middle lactation stage.
3. Results
3.1. Low-Molecular-Weight Protein Profiles from Crude Milk by MALDI-TOF MS
An analysis of peptides and low-molecular-weight proteins (2000–30,000 Da) present in skimmed
raw milk was performed by a benchtop linear MALDI-TOF mass spectrometer. We obtained complex
mass spectra that were not affected by signal background problems. Four independent MALDI-TOF
MS protein profiles from each milk sample were recorded in order to ascertain a high level of analytical
reproducibility for the analysis. Mass spectra obtained from different milk samples from the same
source prepared and run on the same day were virtually indistinguishable, and the relative intensities
of protein species detected in each replicate were constant. Each spectrum was visually inspected, and
the resulting flattened profiles were compared by gel-like representations with spectra from different
samples. Figure 1 reports the MALDI-TOF MS profile and the pseudogel view of human milk samples
analyzed at 2 (colostrum, HC), 30 (HM30), 60 (HM60), and 90 (HM90) days postpartum. In all human
samples, many peaks are visible in the left part of the mass spectrum. After the conversion of the
obtained mass spectra to a gel-like format, it appeared clear that many species below a molecular weight
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of 5000 Da were present especially in the HC samples. In the middle of the spectra (medium-mass
range), many peaks between 8500 and 16,000 Da were present in all samples, whereas no peaks
were detected in the rightmost part of the spectra (>16,000 Da), although the sinapinic acid matrix,
which is beneficial for the ionization of higher molecular weight proteins, was used during the sample
deposition on the MALDI target. It was only in mature milk (HM60 and HM90) that a mass value of
approximately 24,000 Da became detectable.
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reduced number of peaks in the high-mass range compared to other milk. 
Figure 1. Representative matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry
(MALDI-TOF MS) profiling and pseudogel view of crude human milk at two, 30, 60, and 90 days of
lactation, indicated respectively as HC, HM30, HM60, and HM90. The mass-to-change ratios (m/z) are
reported on the X axis (Da), while the peak intensities are indicated as arbitrary units (a.u.) in the gray
scale bar on the Y axis.
Figure 2 shows the MALDI-TOF MS profile and the pseudogel view relative to four commercial
infant formulas (A, H, F and N). The distribution of molecular weights observed in the mass range
between 2000 and 30,000 Da was similar in formula F, H, and N, while formula A displayed peaks
only in the first part of the spectra, and no detectable signals were observed in the high-mass range,
although it was not a hydrolysate formula. A faint signal above background at approximately m/z
18,000 was detectable for both formula H and N.
Figure 3 reports the mass spectra and the relative pseudogel view of other mammalian milk
analyzed in the present study: cow milk (CM), buffalo milk (BM), goat milk (GM), ewe milk (EM),
donkey milk (DM), and camel milk (CAM). All animal milk samples contain several peaks in the low-,
medium- and high-mass range.
In the region of the mass spectra <10,000 Da, many spectrometric signals were detectable except
from EM. As in human and formula milk, a mass value of approximately 14,000 Da predominated
in all animal samples. Conversely, the mass spectra of animal milk samples showed two intense
peaks at approximately 18,000 (missing in human samples as well as CAM) and 24,000 Da (missing in
HC, HM30 as well as in DM and CAM). In our conditions, CAM milk showed a profile displaying a
reduced number of peaks in the high-mass range compared to other milk.
Nutrients 2018, 10, 1238 6 of 13Nutrients 2018, 10, x FOR PEER REVIEW  6 of 13 
 
 
Figure 2. Representative MALDI-TOF MS profiling and pseudogel view of commercial starting 
formula from four different companies (Aptamil 1, A; Formulat 1 from Dicofarm, F; Humana 1, H; 
Nidina 1 from Nestlé, N). The mass-to-change ratios (m/z) are reported on the X axis (Da), while the 
peak intensities are indicated as arbitrary units (a.u.) in the gray scale bar on the Y axis. 
 
Figure 3. Representative MALDI TOF MS profiling and pseudogel view of crude milk from cow milk 
(CM), buffalo milk (BM), goat milk (GM), ewe milk (EM), donkey milk (DM), and camel milk (CAM). 
The mass-to-change ratios (m/z) are reported on the X axis (Da), while the peak intensities are 
indicated as arbitrary units (a.u.) in the gray scale bar on the Y axis. 
Figure 2. Representative MALDI-TOF MS profiling and pseudogel view of commercial starting formula
from four different companies (Aptamil 1, A; Formulat 1 from Dicofarm, F; Humana 1, H; Nidina 1
from Nestlé, N). The mass-to-change ratios (m/z) are reported on the X axis (Da), while the peak
intensities are indicated as arbitrary units (a.u.) in the gray scale bar on the Y axis.
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Figure 3. Representative MALDI TOF MS profiling and pseudogel view of crude milk from cow milk
(CM), buffalo milk (BM), goat milk (GM), ewe milk (EM), donkey milk (DM), and camel milk (CAM).
The mass-to-change ratios (m/z) are reported on the X axis (Da), while the peak intensities are indicated
as arbitrary units (a.u.) in the gray scale bar on the Y axis.
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3.2. Milk Spectra Properties and Similarities
To evaluate the similarities and differences among peptide and protein compositions of different
milk samples, we used an external statistical software (R Bioconductor) to perform a correlation
analysis on spectral values (m/z and intensities) extracted after ClinProToolsTM bioinformatics
software preprocessing.
Figure 4 displays the correlation matrix obtained from all of the spectra. The figure represents
three wide subgroups: the first group of animal milk (BM, CAM, CM, DM, EM, and GM), the second
group of human milk (HC, HM30, HM60, and HM90), and the third group of formula milk (A, F, H,
and N). From a visual analysis, animal milk does not have an appreciable correlation with human
or formula milk. CAM displayed a very poor correlation with all of the considered milk. This may
suggest that this milk might have a different protein profile compared to other animal milk. BM has a
relatively strong correlation with CM and to a lesser extent with EM and GM, which is in agreement
with our previous study [26]. Human colostrum has a good correlation with mature human milk,
but HM30, HM60, and HM90 are more correlated between them. Of note, although well correlated
with each other, none of the milk formulae analyzed in this study displayed an appreciable correlation
with animal or human milk.
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Figure 4. Pearson’s correlation matrix of all spectral replica datasets for animal milk (BM, CAM, CM,
DM, EM, and GM), human milk at 2, 30, 60 and 90 days (HC, HM30, HM60 and HM90, respectively),
and infant formula (A, F, H, N). Correlation coefficients are represented with decreasing blue and
yellow colors according to a scale ranging from 0 to 1, respectively.
These considerations were also supported by the hierarchical clustering tree (Figure 5) determined
by the statistical software, R Bioconductor. The camel milk cluster separated from the other three
clades that represent the group of formula milk, animal milk, and human milk. Formula milk from
four different companies displayed a relatively homogeneous clustering, suggesting moderately
common spectral characteristics. However, differences among the different brands allowed us to
identify a common subcluster for each brand, ev n across its different batches. The group of human
mature milk clustered near the colostrum clade, whereas the animal milk group was relatively well
separated. The spectra were then analyzed by principal component analysis (PCA) using the integrated
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software ClinProToolsTM. As shown in Figure 6, the milk samples of the same species closely clustered
together, whereas the different milk species were well separated each other. The 3D scatter plot
image obtained from the PCA analysis indicates that seven MALDI-TOF MS profiles can be grouped,
again corresponding to breast milk (with the two subgroups of colostrum and the other stages of breast
milk), starting formulae, CM, BM, GM/EM, DM, and CAM.
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Figure 6. 3D scatter plot image from the pri ci al c e t analysis (PCA) for human milk at 2, 30,
60, and 90 days (HC, HM30, HM60, and 90, respectively), infant formula milk (A, F, H, and N),
and animal milk (CM, BM, GM, EM, DM and CA ). Each spot represents one milk sample.
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4. Discussion
In the current study, we focused our interest on protein content that serves diverse biological
activities in milk such as providing essential amino acids to growing infants, supplying newborns
with enzymatic activity, and making available vitamins and hormones. Proteins are present in milk
with a very large dynamic range in their concentrations [27]. After a defatting operation consisting
in a two-step centrifugation, the milk fat globule membrane proteins were lost in great part together
with their lipid counterpart, and the protein content of all samples resulted principally in caseins and
soluble whey proteins. We then conducted a qualitative MALDI-TOF MS-based analysis of defatted
milk to evaluate the similarities and differences in low-molecular-weight profiles of the composition of
milk from a different source.
Multiple components were detected as clear signals in the mass range of 2000–30,000 Da.
This region is known to represent milk proteins and peptides with pivotal roles in infants’ health and
development such as antimicrobial activities (e.g., lysozyme, 16 kDa and lactalbumin, 14 kDa) and
mineral absorption functions (e.g., caseins, between 20 and 25 kDa). Furthermore, most of the bioactive
factors are peptides originally present in milk, which may exert their biological activity in the upper
gastrointestinal tract regardless of digestive processes [19].
Our data indicate that the human colostrum profile (<30,000 Da) is more complex than every
other kind of milk (Figures 1–3). Colostrum, secreted in the few days after birth, is reported to
contain higher amount of peptides, proteins, and vitamins compared to mature milk [28]. The unique
characteristics of HC, with additional nutrients and immune and growth factors, make it interesting
as a therapy to promote neonatal health [28,29]. We found that HC spectra are particularly rich in
low-molecular-weight proteins and are dominated by spectrometric signals with a mass <10,000 Da
and mainly <7000 Da, a significant fraction of which may be involved in its physiological characteristics.
Based on the linear MALDI-TOF MS, our analysis does not allow us to identify any milk proteins,
but it clearly indicates that the milk protein profile changes gradually over the following 30 days after
birth. The amount of peptides and proteins decreases rapidly during the first month of lactation and
then stabilizes in “mature” milk after 60 days (HM60 and HM90; Figure 1). By contrast, polypeptides
of approximately 15,000 Da remain stable across colostrum and mature milk. A noteworthy finding
was that the appearance of spectrometric signals with an m/z value of approximately 24,000 Da in
mature milk (HM60 and HM90) was concomitant to a decrease in components with a molecular
weight <12,000 Da. In agreement with these data, proteomic studies have shed light on the dynamic
composition of human milk throughout lactation stages [18,30–32]. In particular, whey proteins
implicated in the modulation of the immune system and in the maturation of the gastrointestinal tract
of neonates are overrepresented in the human milk during the first days of lactation.
A hierarchical cluster analysis of the mass spectra was used to group milk samples according
to the similarity of their spectral profiles. In this unsupervised analysis, the group assignment of
the protein/peptides expression patterns was generated based on the similarities of spectral patterns
in the automatic selected peaks. This analysis demonstrated that all analyzed milk samples formed
four main clusters (Figure 5). All human samples (n = 20) formed a cluster in which milk at 30, 60,
and 90 days constituted a well-defined subcluster. These results indicate that colostrum could be clearly
differentiated by signal patterns of their MALDI-TOF mass spectra as an out-group. Even more clearly,
the PCA of the qualitative characteristics generated seven principal components (PCs) (Figure 6).
Human milk was segregated into a single PC, in which HC (brown dots) was identified as different
from human milk samples at different stages of lactation (green dots).
The spectra relative to the commercial starting formulae reported in Figure 2 were from four
different brands in which bovine milk is the only source of protein (e.g., casein alone, whey proteins
together with caseins, etc.) while fat content was derived from a mixture of vegetable oil. Each group
included four different samples of the same formula, coming from different batches. The linear
MALDI-TOF MS technique was able to identify a consistent similarity among the profiles of different
milk samples. All formulae displayed a profile consistently different from cow’s milk, which is
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their parent protein source. This is consistent with the ESPGHAN recommendations for the protein
composition of infant formulae (12), which were modified such as the formulae studied were all
enriched in whey protein fractions and lowered in caseins. However, each brand was characterized by
a specific protein profile. Although all 16 samples of infant formula formed a tight cluster (Figure 5),
each brand could be differentiated, indicating that the proteomic asset of each formula was stable
across batches and could be identified in a blinded, unsupervised analysis.
The animal milk analyzed in the present study showed similar protein peak profiles ranging
from 14,000 to 18,000 Da (Figure 3). In particular, these spectrometric signals were conserved across
CM, BM, GM, EM, and DM but were less evident in CAM. The spectrometric signals at 18,000 Da
and 24,000 Da correspond, respectively, to the theoretical molecular weights of lactoglobulin and
casein—two components of cow milk responsible for cow’s milk allergy (CMA), the most common
food allergy affecting children [33]. The absence of these spectrometric signals in the CAM sample and
in all analyzed human milk is in agreement with previous studies that report the lack of these proteins
in camel milk [34,35]. For this reason, CAM, although not extensively used, was recommended
by pediatricians for children with a cow’s milk allergy and hence was evaluated in the present
work [34,36–39].
GM and EM clearly displayed two additional peaks at 20,000 and 25,000 Da, which was less
evident in CM and BM. They were absent in donkey milk, which was characterized by a notoriously
low protein content (1.3–2.8 g/100 mL) and by a high whey protein/casein ratio [40]. The hierarchical
cluster analysis of peak profiles indicated that 24 samples of five types of animal’s milk could be
subcategorized by source: a subcluster identified DM vs. bovidae milk (buffalo, goat, ewe, cow),
another included all seven BM samples, and a third was composed by the 13 samples of CM, EM,
and GM. The results indicate that cow, ewe, and goat milk have a homogeneous milk proteome,
while milk proteins from donkey and cow milk share a low-sequence similarity due to the genetic
distance between the Equidae and Bovidae families. Indeed, there is evidence of cross-reactivity between
cow milk and proteins from goat, sheep and buffalo milk [20], while substantial differences in the
IgE-binding epitope of cow milk proteins and the corresponding domains of donkey milk protein may,
besides the low content in caseins, account for the demonstrated reduced allergenicity of DM [41].
Its distinctive protein composition is also evident in the results of our PCA, where we were able
to differentiate between BM and CM samples and also between these ones and DM. The only two
kinds of milk that clustered together were from ewe and goat samples, which was not a surprising
finding if we consider the taxonomic proximity between goats and sheep (i.e., Caprinae subfamily) and
the well-known clinical cross-reactivity among their milk [42]. Conversely, camel milk is completely
different from any other mammalian milk from a proteomic point of view. The same observation stems
from the PCA reported in Figure 6, where CAM is segregated with a different color. These results
confirm the moderately different protein composition of camel milk compared to other animals’
milk [43]. Among the mammalian species that are proposed to be suitable as a valid substitute of cow’s
milk-based formulas, the CAM has a unique spectra profile that could have interesting properties in
the nutrition of children.
These findings seem to suggest that the choice of an alternative to breast milk cannot be made
exclusively on the basis of macronutrient composition, but that the proteomic profile can be a useful
evaluation tool [44,45]. Their results may be even more relevant if they will be replicated in extensively
hydrolyzed milk formulae (eHFs). These formulae are the first-choice milk substitutes in CMA, but may
carry residual allergens that are able to cause reactions in sensitive infants [21]. A recent proteomic
analysis revealed that the peptide profiles of commercially available eHFs also provide a descriptive
and distinct signature [46].
5. Conclusions
MALDI-TOF MS profiling of milk proteins in combination with statistic tools proved to be a high
throughput and low-cost approach with promising applications as an analytical tool to quickly assess
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the similarities and differences of low-molecular-weight proteins present in milk from different sources
with a high level of accuracy and sensitivity. Our data point to differences between the potential
alternative sources of infant formula milk and create the basis for further proteomic investigations to
achieve more conclusive results on the protein content of the milk types herein evaluated.
Moreover, a MALDI-TOF mass spectral database compilation can assist nonspecialized mass
spectrometric laboratories for a rapid screening and characterization of milk samples. The screening
procedures could become a powerful method for analyzing milk in a blinded way in order to evaluate
animal milk adulterations, milk samples present in human donor breast milk banking, and matching
between human-milk formula compositions. A rapid MALDI- TOF MS assay could also become an
instrument for interpreting the individuality in the phenotypic expression of allergies to cow’s milk
proteins and beyond.
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